137 related articles for article (PubMed ID: 29095152)
21. Staphylococcal enterotoxin microbial superantigens.
Johnson HM; Russell JK; Pontzer CH
FASEB J; 1991 Sep; 5(12):2706-12. PubMed ID: 1916093
[TBL] [Abstract][Full Text] [Related]
22. Structural and functional role of threonine 112 in a superantigen Staphylococcus aureus enterotoxin B.
Baker MD; Papageorgiou AC; Titball RW; Miller J; White S; Lingard B; Lee JJ; Cavanagh D; Kehoe MA; Robinson JH; Acharya KR
J Biol Chem; 2002 Jan; 277(4):2756-62. PubMed ID: 11704673
[TBL] [Abstract][Full Text] [Related]
23. Antagonistic effects of the staphylococcal enterotoxin a mutant, SEA(F47A/D227A), on psoriasis in the SCID-hu xenogeneic transplantation model.
Boehncke WH; Hardt-Weinelt K; Nilsson H; Wolter M; Dohlsten M; Ochsendorf FR; Kaufmann R; Antonsson P
J Invest Dermatol; 2001 Apr; 116(4):596-601. PubMed ID: 11286628
[TBL] [Abstract][Full Text] [Related]
24. Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A.
Bavari S; Dyas B; Ulrich RG
J Infect Dis; 1996 Aug; 174(2):338-45. PubMed ID: 8699064
[TBL] [Abstract][Full Text] [Related]
25. Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model.
Inskeep TK; Stahl C; Odle J; Oakes J; Hudson L; Bost KL; Piller KJ
Clin Vaccine Immunol; 2010 Aug; 17(8):1163-9. PubMed ID: 20554806
[TBL] [Abstract][Full Text] [Related]
26. Evidence for a functional interaction between the beta chain of major histocompatibility complex class II and the T cell receptor alpha chain during recognition of a bacterial superantigen.
Deckhut AM; Chien Y; Blackman MA; Woodland DL
J Exp Med; 1994 Nov; 180(5):1931-5. PubMed ID: 7964468
[TBL] [Abstract][Full Text] [Related]
27. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
28. Selection of phage-displayed superantigen by binding to cell-surface MHC class II.
Wung JL; Gascoigne NR
J Immunol Methods; 1997 May; 204(1):33-41. PubMed ID: 9202707
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the functional regions of the superantigen staphylococcal enterotoxin B.
Zhang L; Rogers TJ
Toxins (Basel); 2013 Oct; 5(10):1859-71. PubMed ID: 24152989
[TBL] [Abstract][Full Text] [Related]
31. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B.
Kappler JW; Herman A; Clements J; Marrack P
J Exp Med; 1992 Feb; 175(2):387-96. PubMed ID: 1370682
[TBL] [Abstract][Full Text] [Related]
32. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model.
Woody MA; Krakauer T; Stiles BG
Vaccine; 1997 Feb; 15(2):133-9. PubMed ID: 9066029
[TBL] [Abstract][Full Text] [Related]
33. T cell receptor V alpha 4 is expressed by a subpopulation of V beta 6 T cells that respond to the bacterial superantigen staphylococcal enterotoxin B.
Borrero H; Donson D; Cervera C; Rexer C; Macphail S
J Immunol; 1995 May; 154(9):4247-60. PubMed ID: 7722285
[TBL] [Abstract][Full Text] [Related]
34. Computational Construction of a Single-Chain Bi-Paratopic Antibody Allosterically Inhibiting TCR-Staphylococcal Enterotoxin B Binding.
Bai G; Ge Y; Su Y; Chen S; Zeng X; Lu H; Ma B
Front Immunol; 2021; 12():732938. PubMed ID: 34887850
[TBL] [Abstract][Full Text] [Related]
35. Structural basis for the interaction of superantigen with the alternative superantigen-binding receptor p85.
Rogers TJ; Zhang L
Mol Immunol; 1997 Feb; 34(3):263-72. PubMed ID: 9224968
[TBL] [Abstract][Full Text] [Related]
36. Rapid clearance of the bacterial superantigen staphylococcal enterotoxin B in vivo.
Vabulas R; Bittlingmaier R; Heeg K; Wagner H; Miethke T
Infect Immun; 1996 Nov; 64(11):4567-73. PubMed ID: 8890208
[TBL] [Abstract][Full Text] [Related]
37. Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity.
Boles JW; Pitt ML; LeClaire RD; Gibbs PH; Torres E; Dyas B; Ulrich RG; Bavari S
Clin Immunol; 2003 Jul; 108(1):51-9. PubMed ID: 12865071
[TBL] [Abstract][Full Text] [Related]
38. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC.
Wang S; Li Y; Xiong H; Cao J
Immunol Lett; 2008 Dec; 121(2):167-72. PubMed ID: 19028523
[TBL] [Abstract][Full Text] [Related]
39. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Brogan PA; Shah V; Klein N; Dillon MJ
Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
[TBL] [Abstract][Full Text] [Related]
40. Structure-function studies of T-cell receptor-superantigen interactions.
Li H; Llera A; Mariuzza RA
Immunol Rev; 1998 Jun; 163():177-86. PubMed ID: 9700510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
